JAMA Network
About The Study: This study of surveillance data from the Vaccine Safety Datalink that included 15.1 million doses of COVID-19 vaccines investigated cases and incidence of Guillain-Barré syndrome (GBS) following vaccination and assessed the risk of GBS after vaccination with the Janssen, Pfizer-BioNTech or Moderna COVID-19 vaccines.
Authors: Nicola P. Klein, M.D., Ph.D., of Kaiser Permanente Northern California in Oakland, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2022.8879)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
